Clinical Trials
334 trialsComparing Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in Patients With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic Radiosurgery
NRG Oncology
Radiation Therapy vs. Observation Following Gemcitabine and Cisplatin for Inoperable Localized Liver Cancer
NRG Oncology
Testing the Addition of Targeted Radiation Therapy to Surgery and the Usual Chemotherapy Treatment (Pemetrexed and Cisplatin [or Carboplatin]) for Stage I-IIIA Malignant Pleural Mesothelioma
NRG Oncology
Continues Cicatricial Perfusion of Ropivacaine Versus Placebo After Mastectomy : Rehabilitation After Treatment
Institut Paoli-Calmettes
SPECTRO GLIO
Institut Claudius Regaud
FLUBUTBI
Hackensack Meridian Health
Cold Atmospheric Plasma Device Extension Study
Medical University of South Carolina
CHARM
Milton S. Hershey Medical Center
TSARINE
Centre Oscar Lambret
MorphinOgel
University Hospital, Strasbourg, France
REPLACE
Translational Research in Oncology
TRIPLEX
Norwegian University of Science and Technology
AlloRelapseMM
Universitätsklinikum Hamburg-Eppendorf
SURGIGAST
University Hospital, Lille
AXIL95
Institut Bergonié
PREVENT
University Hospital, Geneva
CLODIS
Centre Francois Baclesse
A Phase III Trial in NPC With Post-radiation Detectable Plasma EBV DNA
National Health Research Institutes, Taiwan
Pre- Versus Post-operative SRS for Resectable Brain Metastases
AHS Cancer Control Alberta
RABITO
Rijnstate Hospital
Olanzapine for the Prevention of Chemotherapy Induced Nausea and Vomiting in Gynecologic Oncology Patients
University of Michigan Rogel Cancer Center
FAMIAN
Wuerzburg University Hospital
ATG Plus Low-dose PT-Cy for GVHD Prevention
Peking University People's Hospital
Adjuvant Aspirin Treatment for Colon Cancer Patients
Swiss Cancer Institute
XXL_2022-01
Groupe Oncologie Radiotherapie Tete et Cou
DEXAML-03
University Hospital, Toulouse
UF-BMT-LDND-101
University of Florida
Volatile Anaesthesia and Perioperative Outcomes Related to Cancer: the VAPOR-C Trial
Peter MacCallum Cancer Centre, Australia
MITO32
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase III RCT of Radiotherapy Plus Toripalimab Versus Sorafenib in Advanced Hepatocellular Carcinoma With PVTT
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
PREPARE
AIO-Studien-gGmbH
BRP30
CR-CSSS Champlain-Charles-Le Moyne
Pulmonary Rehabilitation Before Lung Cancer Resection
Alliance for Clinical Trials in Oncology
MIST
Alliance for Clinical Trials in Oncology
Standard Therapy With or Without Surgery and Mitomycin C in Treating Patients With Advanced Limited Peritoneal Dissemination of Colon Cancer
Alliance for Clinical Trials in Oncology
Tranexamic Acid Use to Reduce Blood Transfusion in Pediatric Cancer Patients Undergoing Limb Salvage Procedure
St. Jude Children's Research Hospital
RESCUE-GC
Peking University Cancer Hospital & Institute
Perioperative Analgesia on Postoperative Opioid Usage and Pain Control in H&N Cancer Surgery
Case Comprehensive Cancer Center
PRIME
Canadian Urologic Oncology Group
Conventional Androgen Deprivation Therapy (ADT) With or Without Abiraterone Acetate + Prednisone and Apalutamide Following a Detectable PSA After Radiation and ADT
Dana-Farber Cancer Institute
ICTAN
Sun Yat-sen University
Trial of ADT and SBRT Versus SBRT for Intermediate Prostate Cancer
Memorial Sloan Kettering Cancer Center
SBRTvsTACE
Lahey Clinic
Pilot Study of Liposomal Bupivacaine Redosing in Patients Undergoing Major Gynecologic Procedures
University of California, Irvine
GLORY
Sun Yat-sen University
GM1 Prophylaxis for Post-chemotherapy Cognitive Impairment in Patients With Early Operable Breast Cancer
Sun Yat-sen University
IL-2
Nova Scotia Health Authority
To Evaluate the Optimal Timing of Postoperative Radiotherapy in Patients With IIIA(N2) Non-Small Cell Lung Cancer
Shanghai Chest Hospital
Epoetin Alfa in Advanced Non-Small Cell Lung Cancer (EPO-CAN-20)
Ontario Clinical Oncology Group (OCOG)
Transarterial Chemoembolization Compared With Stereotactic Body Radiation Therapy or Stereotactic Ablative Radiation Therapy in Treating Patients With Residual or Recurrent Liver Cancer Undergone Initial Transarterial Chemoembolization
Stanford University